Business
PetLife Announces its All-natural 'Cancer Cocktail' With Applicability to Pet and Human Markets
PetLife Announces its All-natural 'Cancer Cocktail' With Applicability to Pet and Human Markets.
About this update from Petlife Pharmaceuticals Inc
[{"type":"text","content":"\n\n\n\nPetLife Announces its All-natural 'Cancer Cocktail' With Applicability to Pet and Human Markets\n\n\n\n\n\nPetLife Announces its All-natural 'Cancer Cocktail' With Applicability to Pet and Human Markets\nThe Company may be the first to offer an all-natural 'cancer cocktail' combining the therapeutic benefits of the plant and animal kingdoms\nPR Newswire\nHANCOCK, Maryland, June 14, 2017\n\n\n\nHANCOCK, Maryland, June 14, 2017 /PRNewswire/ --\n\nPetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the \"Company\"), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, reports on its solution to the ever increasing problem of drug resistance and high toxicity in the treatment of cancer in pets and humans. Each year, in the U.S. alone, more than eleven million cases of cancer in dogs and cats are reported, a number that continues to increase annually.\n\nPetLife's new patent-pending formulation has created a 'cancer cocktail' combining both Blue Scorpion Venom Chlorotoxin with plant-based phytonutrients. Preliminary testing has shown inhibition against certain cancer cell line studies without toxicity. Across the world, researchers have recognized that many cells which cause disease, have the ability to become resistant to treatment when only one drug is used. Combination therapy is increasing, recommended for the treatment of both neoplastic (cancer) and infectious disease. The 'HIV Cocktail', which changed the world's approach to the treatment of HIV, is a similar approach comparison. PetLife's new 'cancer cocktail' may prove to be the non-toxic alternative to the harmful and sometimes deadly side effects of radiation and chemotherapy. The patent pending formulation of PetLife's new 'cancer cocktail' has the curious ability to bind selectively to cancer cells and inhibit their growth demonstrating little to no side effects to the patient.\n\nFor hundreds, if not thousands of years, plant-based medicinals have formed the foundation of therapeutic treatment in the Chinese, Native American and Ayurvedic traditions. More recently, scientists have discovered the mode of action of many of these therapies. In many cases, the chemical compounds have been manipulated or synthesized to create new chemical entitles (\"NCE\"). Along with the creation of NCEs comes ...